J
J. Mark Petrash
Researcher at Anschutz Medical Campus
Publications - 113
Citations - 6143
J. Mark Petrash is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Aldose reductase & Reductase. The author has an hindex of 41, co-authored 107 publications receiving 5610 citations. Previous affiliations of J. Mark Petrash include Emory University & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Correction: Corrigendum: Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome
Miguel A. Lanaspa,Takuji Ishimoto,Nanxing Li,Christina Cicerchi,David J. Orlicky,Philip A. Ruzycki,Christopher J. Rivard,Shinichiro Inaba,Carlos A. Roncal-Jimenez,Elise S. Bales,Christine P. Diggle,Aruna Asipu,J. Mark Petrash,Tomoki Kosugi,Shoichi Maruyama,Laura G. Sánchez-Lozada,James L. McManaman,David T. Bonthron,Yuri Y. Sautin,Richard J. Johnson +19 more
TL;DR: This paper presents a new probabilistic method for estimating the response of the immune system to EMTs to laser-spot assisted, 3D image analysis of EMMARM, which shows clear patterns in the response to laser beams.
Journal ArticleDOI
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Ronald G. Tilton,Katherine Chang,Khalid S Hasan,Samuel R. Smith,J. Mark Petrash,Thomas P. Misko,William M. Moore,Mark G. Currie,John A. Corbett,Michael L. McDaniel,Joseph R. Williamson +10 more
TL;DR: A role for a relative or absolute increase in NO production in the pathogenesis of early diabetic vascular dysfunction is suggested and the possibility that inhibition of diabetic vascular functional changes by aminoguanidine may reflect inhibition of NO synthase activity rather than, or in addition to, prevention of AGE formation is raised.
Journal ArticleDOI
Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome
Miguel A. Lanaspa,Takuji Ishimoto,Nanxing Li,Christina Cicerchi,David J. Orlicky,Philip A. Ruzycki,Christopher J. Rivard,Shinichiro Inaba,Carlos A. Roncal-Jimenez,Elise S. Bales,Christine P. Diggle,Aruna Asipu,J. Mark Petrash,Tomoki Kosugi,Tomoki Kosugi,Shoichi Maruyama,Laura G. Sánchez-Lozada,James L. McManaman,David T. Bonthron,Yuri Y. Sautin,Richard J. Johnson,Richard J. Johnson +21 more
TL;DR: It is demonstrated that mice unable to metabolize fructose are protected from an increase in energy intake and body weight, visceral obesity, fatty liver, elevated insulin levels and hyperleptinemia after exposure to 10% glucose for 14 weeks and concluded that endogenous fructose generation and metabolism in the liver represents an important mechanism whereby glucose promotes the development of metabolic syndrome.
Journal ArticleDOI
Temperature-dependent Chaperone Activity and Structural Properties of Human αA- and αB-crystallins
TL;DR: In this paper, the chaperone activity and biophysical properties of recombinant human alphaA- and alphaB-crystallins were studied by light scattering and spectroscopic methods.
Journal Article
Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.
TL;DR: Results indicate that tannoids of E. officinalis are potent inhibitors of AR and suggest that exploring the therapeutic value of natural ingredients that people can incorporate into everyday life may be an effective approach in the management of diabetic complications.